These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 27590035)

  • 1. Urine Creatinine Concentrations in Drug Monitoring Participants and Hospitalized Patients.
    Love SA; Seegmiller JC; Kloss J; Apple FS
    J Anal Toxicol; 2016 Oct; 40(8):659-662. PubMed ID: 27590035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of lowering the screening and confirmation cutoff values for urine drug testing based on dilution indicators.
    Fraser AD; Zamecnik J
    Ther Drug Monit; 2003 Dec; 25(6):723-7. PubMed ID: 14639059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An investigation of normal urine with a creatinine concentration under the cutoff of 20 mg/dL for specimen validity testing in a toxicology laboratory.
    Holden B; Guice EA
    J Forensic Sci; 2014 May; 59(3):806-10. PubMed ID: 24502684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Adulteration of urine drug testing--an exaggerated cause of concern].
    Beck O; Bohlin M; Bragd F; Bragd J; Greitz O
    Lakartidningen; 2000 Feb; 97(7):703-6. PubMed ID: 10740378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beating the system: a study of a creatinine assay and its efficacy in authenticating human urine specimens.
    Villena VP
    J Anal Toxicol; 2010; 34(1):39-44. PubMed ID: 20109301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normalization of urinary drug concentrations with specific gravity and creatinine.
    Cone EJ; Caplan YH; Moser F; Robert T; Shelby MK; Black DL
    J Anal Toxicol; 2009; 33(1):1-7. PubMed ID: 19161663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of a methadone metabolite (EDDP) in urine: assessment of compliance.
    Larson ME; Richards TM
    Clin Med Res; 2009 Dec; 7(4):134-41. PubMed ID: 19920164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An investigation into the extent of possible dilution of specimens received for urinary drugs of abuse screening.
    George S; Braithwaite RA
    Addiction; 1995 Jul; 90(7):967-70. PubMed ID: 7663318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creatinine in urine - a method comparison.
    Luginbühl M; Weinmann W
    Drug Test Anal; 2017 Oct; 9(10):1537-1541. PubMed ID: 28102586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urine-creatinine concentration as a marker of urine dilution: reflections using a cohort of 45,000 samples.
    Arndt T
    Forensic Sci Int; 2009 Apr; 186(1-3):48-51. PubMed ID: 19216038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Workplace drug testing on urine samples: evidence for improving efficacy of a first-level screening programme.
    Crespi V; Maio RC; Veronesi G; Gianfagna F; Taborelli S; Ferrario MM
    Med Lav; 2015 Sep; 106(5):374-85. PubMed ID: 26384263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catching Fakes: New Markers of Urine Sample Validity and Invalidity.
    Goggin MM; Tann CM; Miller A; Nguyen A; Janis GC
    J Anal Toxicol; 2017 Mar; 41(2):121-126. PubMed ID: 27881620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specimen validity testing in urine drug monitoring of medications and illicit drugs: clinical implications.
    Kirsh KL; Christo PJ; Heit H; Steffel K; Passik SD
    J Opioid Manag; 2015; 11(1):53-9. PubMed ID: 25750165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creatinine normalization of workplace urine drug tests: does it make a difference?
    Price JW
    J Addict Med; 2013; 7(2):129-32. PubMed ID: 23370934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of creatinine reference value: Normalization of urinary drug concentrations.
    Aydoğdu M; Oral S; Akgür SA
    J Forensic Sci; 2021 Sep; 66(5):1855-1861. PubMed ID: 33904587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids?
    Manchikanti L; Manchukonda R; Pampati V; Damron KS; Brandon DE; Cash KA; McManus CD
    Pain Physician; 2006 Apr; 9(2):123-9. PubMed ID: 16703972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between blood- and urine-amphetamine concentrations in impaired drivers as influenced by urinary pH and creatinine.
    Jones AW; Karlsson L
    Hum Exp Toxicol; 2005 Dec; 24(12):615-22. PubMed ID: 16408614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of freezing point depression osmolality for classifying random urine specimens defined as substituted under HHS/DOT criteria.
    Cook JD; Hannon MW; Vo T; Caplan YH
    J Anal Toxicol; 2002 Oct; 26(7):424-9. PubMed ID: 12422996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing urine drug testing for monitoring medication compliance in pain management.
    Melanson SE; Ptolemy AS; Wasan AD
    Pain Med; 2013 Dec; 14(12):1813-20. PubMed ID: 23899241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.